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Abstract Ser-Ala and Ser-Ala-Ser-Ala C-terminus elongated 
(A+2 and A+4, respectively) and two C-terminus deleted (A--2 
and A--3) muscle acylphosphatase mutants were investigated to 
assess the catalytic and structural roles of the C-terminal region. 
The kinetic analysis of these mutants shows that the removal of 
two or three C-terminal residues reduces the catalytic activity to 
7% and 4% of the value measured for the wild-type enzyme, 
respectively; instead, the elongation of the C-terminus does not 
significantly change the enzyme behaviour. 1H Nuclear magnetic 
resonance spectroscopy indicates that all mutants display a 
native-like fold though they appear less stable, particularly A--2 
and A-3  mutants, as compared to the wild-type enzyme. Such 
destabilisation of the C-terminal modified mutants is further 
confirmed by urea inactivation experiments. The results here 
presented account for an involvement of the C-terminal region in 
the stabilisation of the three-dimensional structure of acylpho- 
sphatase, particularly at the active-site level. Moreover, a 
participation of the C-terminal carboxyl group to the catalytic 
mechanism can be excluded. 
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1. Introduction 
Acylphosphatase (E.C. 3.6.1.7) is a very small protein (Mr 
11 365, horse muscle enzyme) widely distributed in vertebrate 
tissues in the form of two isozymes named muscle and ery- 
throcyte (common) type from the tissue/cell in which they are 
most abundant or from which they were first purified [1]. The 
two isozymes hare a high sequence homology ranging from 
over 55% in mammals to about 62% and 70% in birds and 
fish, respectively ([2] and unpublished results). The two iso- 
zymes are probably derived from a common ancestor gene by 
duplication and subsequent evolution. Acylphosphatase iso- 
zymes catalyse the hydrolysis of carboxylphosphate bonds 
present in physiologically important compounds uch as 1,3- 
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Abbreviations: A+2, acylphosphatase mutant containing a Ser-Ala 
extension at the C-terminus; A + 4, acylphosphatase mutant containing 
a Ser-Ala-Ser-Ala extension at the C-terminus; A-2, acylphosphatase 
mutant lacking the C-terminal dipeptide; A--3, acylphosphatase 
mutant lacking the C-terminal tripeptide; IPTG, isopropyl thiogalaeto- 
side; GST, glutathione S-transferase; NMR, nuclear magnetic 
resonance. 
bisphosphoglycerate, carbamoylphosphate, succinylpho- 
sphate, and the 13-aspartylphosphate formed during the activ- 
ity of membrane ion pumps [1]. It has been suggested that the 
enzyme interferes with the glycolytic flux and enhances the 
rate of alcohol fermentation [3]. Both acylphosphatase iso- 
zymes exert a significant effect on membrane ion transport 
systems [4,5]. Moreover, muscular acylphosphatase expression 
in cultured cells appears as an early differentiation event in the 
myoblast/myotube system [6]. 
The three-dimensional solution structure of the muscular 
isozyme has been determined by 1H NMR spectroscopy [7]. 
The enzyme is a closely packed if-/13 protein composed of five 
I]-strands forming an antiparallel, twisted [3-sheet facing two 
antiparallel a-helices. The secondary structure elements do 
not follow each other in sequence and can be grouped into 
two [3c~13 units interleaved into each other. This fold has been 
found in proteins such as the bacterial histidine-containing 
phosphocarrier p otein (HPr), the bacterial mercuric ion bind- 
ing protein (MerP), the RNA binding domain of the small 
nuclear ibonucleoprotein A, and a few others [8-11]. 
Limited information is currently available on both the en- 
zyme kinetic mechanism and the residues involved in catalysis 
[12]. Recently, two catalytic residues have been identified by 
oligonucleotide-directed mutagenesis ([13] and manuscript 
submitted for publication). In fact, mutants at Arg-23 or 
Asn-41 elicited a dramatically reduced (over 2000-fold) cata- 
lytic efficiency though maintaining the overall native-like fold. 
Arg-23 mutants were completely unable to bind the substrate/ 
competitive inhibitor [13], whereas Asn-41 mutants fully 
maintained this ability (manuscript submitted for publica- 
tion). 
Previous 1H NMR findings indicated the possible location 
of the enzyme active site in the proximity of the C-terminus 
region [14], which is part of the fifth [3-strand of the [3-sheet. 
Later, a nearly complete loss of activity was shown in the 
muscle isozyme lacking the two C-terminal residues (Arg-97 
and Tyr-98), previously removed by carboxypeptidase tr at- 
ment [15]. More recently, the individual importance of Arg97 
and Tyr98 for enzyme activity and stability has been studied 
by the same oligonucleotide-directed mutagenesis approach 
[16], indicating that Arg-97 and Tyr-98 do not directly parti- 
cipate in the catalytic mechanism. Nevertheless, these studies 
did not assess a possible involvement of the carboxy-terminal 
group in catalysis. 
Two deletion (A--2 and A--3) and two insertion (A+2 and 
A+4) enzyme mutants were prepared by oligonucleotide-direc- 
ted mutagenesis. These mutants were studied to definitely un- 
derstand the role of both the C-terminal region and the car- 
boxy-terminal group in the muscle-type acylphosphatase 
active site function and stabilisation. 
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2. Materials and methods 
2.1. Materials 
Benzoylphosphate was synthesised as previously described [17] and 
dissolved immediately prior to enzyme assays. Specific polyclonal 
anti-recombinant human muscle acylphosphatase antibodies used in 
the Western blot experiments were obtained according to Berti et al. 
[18]. Glutathione, human thrombin, and glutathione-agarose affinity 
gel were from Sigma. D20 and d4-acetic acid were from Merck 
(Darmstadt). Klenow fragment of E. coli DNA polymerase I, T4 
DNA ligase, Taq polymerase, and restriction enzymes BamHI and 
EcoRI were purchased from Promega; sequenase was from USB; 
pGEX-2T vector was from Pharmacia; isopropyl thiogalactoside 
(IPTG) was from Boehringer (Mannheim). Horseradish peroxidase- 
linked mouse anti-rabbit Ig was from Bio-Rad. [o~-32P]ATP (800 Ci/ 
mmol) was from New England Nuclear. The pGEX-AP plasmid was 
obtained as previously described from the pGEX-2T vector harbour- 
ing a chemically synthesised gene coding for human muscle acylpho- 
sphatase [19]. The DH5tx and TBI bacterial strains were used for 
plasmid propagation and recombinant fusion protein expression, re- 
spectively. Chemically synthesised oligonucleotides containing the de- 
sired insertions and deletions were obtained from Pharmacia. All 
other reagents were analytical grade or the best commercially avail- 
able. 
2.2. Oligonucleotide-directed mutagenesis 
A-2 and A--3 deleted genes together with A+2 and A+4 genes were 
obtained by polymerase chain reaction according to Mullis et al. [20]. 
A direct primer harbouring the restriction site for BamHI and anneal- 
ing to the synthetic gene coding for human muscle acylphosphatase 
was designed in order to obtain a correct insertion in the plasmid 
pGEX-2T. Two reverse primers harbouring a stop codon instead of 
the codon for the 97th and 96th amino acid (5'-TCAAATAGA- 
AAAGTTGCTGTA-3', and 5'-AATAGCGTTAAGAAAAGTTGC- 
3') were used in order to obtain the A-2 and A-3 deleted genes, 
respectively. Two reverse primers containing two and four extra co- 
dons at the acylphosphatase g ne sequence corresponding to the en- 
zyme C-terminus (5'-GCGT]?AGGCGCTATAGCGAATAGAAAG- 
3' and 5'-GCGTTAGGCGCTGGCGCTATAGCGAATAGAAAA- 
GTTGCTG-3') were used in order to obtain the A+2 and A+4 genes, 
respectively. 
2.3. Fusion protein expression and enzyme purification 
The mutated sequences were treated with Klenow enzyme and then 
digested with BamHI restriction enzyme. The obtained fragments were 
separately igated into the pGEX-2T plasmid previously digested with 
EcoRI, treated with Klenow and then digested with BamHI. The 
fragments were then inserted ownstream and in frame with the glu- 
tathione S-transferase coding sequence. The recombinant clones were 
isolated by colony hybridisation. All mutations were confirmed by 
DNA sequencing according to Sanger et al. [21]. Mutated protein 
expression was obtained in the E. coli strain TB1 after induction 
with IPTG. The cultures were grown at 37°C under shaking up to 
stationary phase, and the presence of the mutated proteins in cell 
lysates was checked by SDS-PAGE. The GST-acylphosphatase fusion 
proteins were purified from cell lysates as previously reported [19] 
with minor modifications in order to obtain the enzyme in the reduced 
( -SH) form. The purified enzymes were controlled by Western blot 
analysis. Thrombin cleavage was performed by incubating each fusion 
protein with 1:1000 (w/w) human thrombin in 50 mM Tris-HC1 buf- 
fer, pH 8.0, containing 150 mM NaC1 and 2.5 mM CaC12; incubation 
was performed at room temperature for 1 h. Each cleaved enzyme was 
separated from GST and uncleaved fusion protein by gel filtration as 
previously reported [19]. Fractions containing the cleaved enzyme 
were pooled, concentrated and analysed for purity by SDS-PAGE. 
2.4. Protein determination and amino acid analysis 
Protein concentration was determined by UV absorption using an 
A~m2 ~ = 14.2; for the C-terminus deleted enzymes, lacking Tyr98, 
an A~n2s0 = 13.8 was calculated. Amino acid analyses were per- 
formed ]~y a Carlo Erba model 3A29 amino acid analyser equipped 
with an Hewlett Packard HP3395 computing integrator. Values for 
threonine and serine were corrected for residue degradation during 
sample hydrolysis. 
2.5. Acylphosphatase activity measurements 
Acylphosphatase activity was measured by a continuous optical test 
at 283 nm and 25°C using benzoylphosphate as a substrate, as pre- 
viously described [22]. The assay test contained 5 mM benzoylpho- 
sphate in 0.1 M acetate buffer, pH 5.3, unless otherwise stated. Dele- 
tion mutant activity was measured in the presence of an enzyme 
concentration (0.010-0.015 mg/ml) 100100-fold higher than that 
used in the standard assay. 
2.6. Urea inactivation experiments 
Urea inactivation experiments were carried out at 37°C in 50 mM 
acetate buffer, pH 3.8. The urea stock solution was deionised just 
before the experiments by incubation with an AG501X8 ion exchange 
resin (Bio-Rad) for 30 min. The samples were preincubated for 1 h in 
the presence of differing urea concentrations (ranging from 0 to 8 M). 
Enzyme activity was measured in assay mixtures containing the cor- 
responding urea concentrations. 
2. 7. 1H NMR spectroscopy 
The 1H NMR experiments were carried out at 600 MHz using a 
Bruker AMX600 spectrometer. Protein concentration i  samples was 
made 1 2 mg/ml by dissolving the lyophilised enzymes in 50 mM d3- 
acetate buffer/D20, pH 3.8. The samples were immediately used for 
recording one-dimensional H NMR spectra using the acquisition 
parameters previously reported [16]. Protein thermal unfolding was 
followed by recording spectra at different temperatures ranging 
from 30 to 70°C. 512 transients were acquired for all samples. 1,4- 
Dioxane was used as an internal chemical shift reference at 3.74 ppm. 
3. Results and discussion 
Four  synthetic genes coding for human muscle acylpho- 
sphatase have been synthesised. A--2 and A-3  deletion genes 
corresponded to the wild-type enzyme lacking two and three 
C-terminal residues, respectively, whereas A+2 and A+4 inser- 
Table 1 
Main kinetic and stability parameters of mutated and wild-type acylphosphatase 
pH optimum Specific activity (IU/mg) Km (mM) a Ki (mM) b tm (°C) cm (M) 
Wild-type 4.8-5.8 6500 0.36 0.75 53.0 2.65 
A+2 4.8-5.8 5800 0.37 0.77 52.0 2.25 
A+4 4.6-5.6 5100 0.39 0.88 50.5 1.90 
A--2 3.84.8 480 0.82 2.85 48.0 1.65 
A--3 4.005.0 280 1.40 4.70 45.5 1.50 
IU is defined as the enzyme activity which catalyses the hydrolysis of 1 lamol/min of benzoylphosphate at 25°C and pH 5.3. The pH optimum 
was calculated at 25°C, in 0.1 M acetate buffer, pH 3.7-6.0 and in 50 mM 3,3-dimethylglutarate buffer, pH 6.0°7.5. The other kinetic para- 
meters were determined at 25°C in 0.1 M acetate buffer, pH 5.3 (wild-type and insertion mutants) or 4.3 (deletion mutants). Cm is the urea 
concentration required to reduce the enzyme activity to 50°/'o f the value in the absence of urea at 37°C in 50 mM acetate buffer, pH 3.8. tm is 
the temperature needed to denature 50% of the molecules; it was calculated by 1H NMR spectroscopy in 50 mM acetate buffer, pH 3.8, as 
previously described [26]. 
~Using benzoylphosphate s substrate. 
bFor inorganic phosphate as competitive inhibitor. 
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tion genes corresponded to that coding for the wild-type en- 
zyme extended by two and four residues at the C-terminus, 
respectively. The C-terminal extra residues were Ser-Ala (A+2) 
and Ser-Ala-Ser-Ala (A+4). The four mutated genes, together 
with that coding for the wild-type enzyme, were cloned and 
expressed using the four primers described in section 2. The 
wild-type and mutant enzymes were purified from cell lysates 
as described in section 2. The purification yields of the wild- 
type, A+2 and zX+4, were over 5 mg of protein/liter of cell 
culture. In the case of the A--2 and A--3 mutants, the yields 
of purification were significantly lower (less than 1 rag/l), due 
to enzyme precipitation i to cell and during the purification 
steps. Fig. 1 shows the SDS-PAGE of the four purified en- 
zyme mutants together with the wild-type one. Table 1 reports 
the main kinetic data of the purified acylphosphatases. It can 
be seen that the deletion mutants show markedly reduced 
specific activities ranging from 7% (A--2) to about 4% 
(A-3) as compared to the wild-type enzyme, whereas the in- 
sertion mutants display a catalytic activity very similar to that 
of the wild-type acylphosphatase. The decrease of catalytic 
activity observed in the deletion mutants is accompanied by 
a parallel reduction in substrate binding capability. In fact, 
the apparent K~ and the Ki (for inorganic phosphate, an 
enzyme competitive inhibitor) values of deletion mutants in- 
crease progressively following the C-terminus reduction in 
length; instead, the substrate affinity elicited by the insertion 
mutants appears substantially unchanged. This finding sug- 
gests that the amino acid residues (particularly Arg-23) in- 
volved in substrate binding maintain their correct position 
in the insertion mutants. In contrast, in the deletion mutants, 
the active site is likely to suffer a structural perturbation im- 
pairing substrate binding. The low residual activity (about 
7%) of the A--2 mutant partially contrasts with previously 
reported ata indicating that the Tyr-98Arg-97 truncated acyl- 
phosphatase derivative was completely inactive [15]. In prin- 
ciple, the fully inactive C-terminus truncated enzyme can be 
considered identical to the slightly active A -2  mutant. How- 
ever, it should be noted that the truncated erivative was 
obtained from native acylphosphatase by carboxypeptidase 
A digestion at 30°C and pH 7.0 followed by HPLC purifica- 
tion of the so obtained des-Tyr-98 derivative; the latter was 
then subjected to carboxypeptidase B digestion at 30°C and 
pH 7.5. Under these conditions, a partial unfolding of the 
A B C D E F 
Fig. 1. SDS-PAGE of the purified recombinant acylphosphatases. 
Lane A: Mr markers; lane B: wild-type enzyme; lane C: A+4 mu- 
tant; lane D: A+2 mutant; lane E: A-3 mutant; lane F: A--2 mu- 
tant. 
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Fig. 2. Backbone amide, aromatic and aliphatic proton regions of 
the 600 MHz spectra of the wild-type (A), A + 4 (B), A + 2 (C), 
A--2 (D), A--3 (E), acylphosphatases. The spectra were recorded in 
50 mM da-acetate/D20 buffer, pH 3.8, at 37°C. (F) Thermally dena- 
tured (70°C) wild-type enzyme in the same buffer. 
truncated enzyme accompanied by loss of activity is likely 
to have occurred, explaining the complete enzyme inactiva- 
tion. This possibility is supported by the reduced stability of 
the deletion mutants reported in the present study. In another 
paper, it was shown that acylphosphatase Arg-97 to Gln and 
Tyr-98 to Gln mutants maintained over 50% and 65% of the 
wild-type nzyme specific activity, respectively [16]. The sharp 
loss of catalytic efficiency of both deletion mutants described 
here cannot be due to an involvement of the C-terminal 
residues in the catalytic mechanism. Furthermore, the data 
relative to the insertion mutants make a direct participation 
of the terminal carboxylate group in the catalytic mechanism 
unlikely. In fact, in such mutants the elongation of the C- 
terminus, causing a displacement of the carboxylate group, 
was not followed by a significant alteration of the kinetic 
properties. 
A 1H NMR spectroscopy investigation was carried out in 
order to obtain information about the global fold of the mu- 
tants as compared to that of the wild-type. Fig. 2 reports the 
600 MHz 1H NMR spectra of the four enzyme mutants to- 
gether with those of the wild-type enzyme both in the native 
and in the thermally denatured (at 70°C) forms. It is well 
known that the dispersion of proton resonances arises as a 
consequence of persistent contacts characteristic of a stable 
tertiary structure [23]. Such a feature is shown by the spectra 
recorded at 30°C (Fig. 2A-E), confirming the presence of a 
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Fig. 3. Plot of the % enzymatic activity of the recombinant acylpho- 
sphatases vs. urea concentration. 100% is defined as the activity 
measured in the absence of urea. e: wild-type nzyme; (3:h+2 mu- 
tant; []: A--3 mutant. 
native-like fold in all mutants. This finding allows us to ex- 
clude that the relevant loss of activity of the deletion mutants 
is due to a major unfolding. However, the intensity of the 
resonances in the backbone amide proton region (approxi- 
mately above 7.3 ppm) of the deletion mutants pectra is 
significantly reduced as compared to that of the wild-type 
enzyme. In this region, the resonances derive from buried 
protons protected against he exchange with the solvent deu- 
terions. The extent of protection, depending on structural 
fluctuations within the molecule, reflects the presence of a 
well constrained fold [24,25]. Our 1H NMR data at 30°C 
(Fig. 2A-E) suggest that both deletion mutants undergo larger 
structural f uctuation than the wild-type nzyme. This conclu- 
sion is further supported by the behaviour of the different 
proteins upon heating. The 1H NMR spectra of both mutated 
and wild-type nzyme were recorded at different temperatures, 
in the 30-70°C range, using the same acquisition parameters 
and taking into account he time elapsed after sample resus- 
pension (data not shown). Backbone amide proton resonances 
completely disappeared in the deletion mutant and wild-type 
enzyme spectra recorded at 40 and 46°C, respectively, indicat- 
ing a higher susceptibility of the two mutants to deuterion/ 
proton exchange. This finding is indirect evidence of a lower 
stability of both deletion mutants as compared to the wild- 
type enzyme. Furthermore, the analysis of the 1H NMR spec- 
tra recorded at different emperatures nabled us to calculate 
the tm values (temperature at which 50% of the enzyme mol- 
ecules are unfolded) for all mutants, following a previously 
described procedure [26]. Table 1 shows that the insertion 
mutants are slightly more sensitive to temperature as com- 
pared to the wild-type enzyme. The tm values relative to the 
deletion mutants indicate that the removal of two or three 
residues from the C-terminus is responsible for a significant 
reduction of the enzyme stability. 
The stability of all enzymes was further studied using the 
enzymatic activity as a structural probe. Fig. 3 shows part of 
the results of inactivation experiments performed at 37°C un- 
der increasing urea concentrations. The Cm values (Table 1), 
defined as the urea concentrations eeded to reduce the enzy- 
matic activity to 50% of the value calculated in the absence of 
urea, suggest that all mutants, particularly the deletion ones, 
are more sensitive to urea as compared to the wild-type en- 
zyme. 
The data reported here, taken together with previous results 
[15,16], are strongly indicative of an involvement of the C- 
terminal region in acylphosphatase three-dimensional struc- 
ture stabilisation. In fact, the deletion and, to a lesser extent, 
the elongation of the C-terminal region reduce the enzyme 
stability, as indicated by 1H NMR spectra nd urea inactiva- 
tion experiments. Such destabilisation would occur through 
the modification of the fifth I]-strand which is part of the 
antiparallel 13-sheet. The removal of the last two and three 
C-terminal amino acid residues is also responsible for both 
a remarkable loss of activity and a weaker substrate binding 
capability which are likely to arise from a direct destabilisa- 
tion of the active site structure, confirming previous 1H NMR 
data [7] showing the spatial proximity between the two C- 
terminal residues and catalytically relevant residues, such as 
Arg-23 and Asn-41. Moreover, the unchanged kinetic proper- 
ties of the insertion mutants indicate that the terminal carbox- 
ylate group does not participate in catalysis. 
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